Sign in Sign up for free

Last updated: 28 May 2024 at 9:45pm EST

Neal Fowler Net Worth



Neal Fowler biography

Neal Franklin Fowler serves as Chief Executive Officer and Director of the Company. Mr. Fowler also served as a director of Envisia Therapeutics Inc. from November 2013 until November 2017. Mr. Fowler served as a director of Aralez Pharmaceuticals, Inc. (Nasdaq: ARLZ) from June 2010 until August 2018. From June 2006 to March 2008, Mr. Fowler served as president of Centocor, Inc., a subsidiary of Johnson & Johnson, which focused on the development and commercialization of industry leading biomedicines used to treat chronic inflammatory diseases. From July 2004 to June 2006, Mr. Fowler was the president of Ortho McNeil Neurologics, Inc. and from October 2001 to July 2004, the vice president of the central nervous system business of Ortho McNeil Janssen Pharmaceuticals, Inc. From June 1988 to October 2001, Mr. Fowler held a variety of sales, marketing and business development roles at Eli Lilly and Company in the pharmaceutical and medical device divisions. Mr. Fowler graduated from UNC with a Bachelor of Science in Pharmacy and holds a Master of Business Administration from UNC.

What is the salary of Neal Fowler?

As the Chief Executive Officer and Director of Liquidia Corp, the total compensation of Neal Fowler at Liquidia Corp is $1,729,090. There are no executives at Liquidia Corp getting paid more.



How old is Neal Fowler?

Neal Fowler is 58, he's been the Chief Executive Officer and Director of Liquidia Corp since 2008. There are 6 older and 12 younger executives at Liquidia Corp. The oldest executive at Liquidia Corp is Ralph Snyderman, 80, who is the Independent Director.

What's Neal Fowler's mailing address?

Neal's mailing address filed with the SEC is 300 PROFESSIONAL DRIVE, , GAITHERSBURG, MD, 20879.

Insiders trading at Liquidia Corp

Over the last 6 years, insiders at Liquidia Corp have traded over $16,750,945 worth of Liquidia Corp stock and bought 12,456,625 units worth $100,694,400 . The most active insiders traders include Forest Baskett, Scott D Sandell, and Peter J Barris. On average, Liquidia Corp executives and independent directors trade stock every 18 days with the average trade being worth of $1,467,274. The most recent stock trade was executed by Russell Schundler on 30 August 2024, trading 2,344 units of LQDA stock currently worth $23,792.



What does Liquidia Corp do?

liquidia technologies is a biopharmaceutical company transforming the development of new therapies by precisely engineering drug particles. our proprietary print technology is a simple, elegant solution that solves common problems with drug delivery and efficacy. print technology is a scalable cgmp compliant process that creates particles and can apply to virtually any therapeutic area, molecule or route of administration. liquidia is bringing more efficient, controlled development capabilities to the industry while enhancing the safety and quality of products for patients. liquidia is advancing product candidates from its own pipeline. these initial product candidates, liq861 and liq865, apply the print technology to better drug delivery in inhaled and pain therapeutic areas, respectively. the print technology is also licensed with world-leading pharmaceutical companies that are developing future product candidates.



What does Liquidia Corp's logo look like?

Liquidia Corp logo

Liquidia Corp executives and stock owners

Liquidia Corp executives and other stock owners filed with the SEC include: